Alzheimer vei tan beiseina thar? He damdawi thar (Donanemab) chungchang hi han sawi ila.

I chhungkuaa mi tu emaw, i nu duh tak, i pa emaw, i pi emaw pawh ni se, Alzheimer natna vei a nih chuan a hrehawm theih zia kan hria. I hmangaih tak hriatrengna a bo zauh zauh tih hmuh hi a lungchhiatthlak hle. Amaherawhchu, he dinhmun khirh tak karah hian beiseina tlem tal rawn thlen thei thuthang kan sawi a ni. Hei hi natna tihdamna famkim ni lo mah se, hmasawnna pawimawh tak a ni thei.

He thu thar hi eng nge ni?

Tun hnaiah US Food and Drug Administration (FDA) advisory panel chuan lungrual takin Alzheimer natna enkawlna thar atan green light an pe a ni. Damdawi hming chu donanemab a ni . Damlo tan tirh lama damlo tan a tha. He advisory panel pawmpuina hian FDA hian he damdawi hi phalna famkim a pek thuai theihna chance a sang hle tihna a ni. Hei hi thil lian tak a ni tak zet a, a chhan chu Alzheimer ang natna khirh tak enkawlna thar a lo thlen hi beiseina ropui tak a ni.

Donanemab hian engtin nge hna a thawh?

Awle, tunah chuan he damdawi hian engtin nge hna a thawh tih kan en ang. Hei hi a buaithlak deuh a, mahse awlsam takin ka sawifiah ang. Donanemab hi damdawi chi khat a ni a , chu chu monoclonal antibody an ti a . A awlsam zawngin, kan taksa hriselna (immune system) thenkhat hmanga target bik beih theihna tura lab-a siam protein bik a ni. He damdawi hian eng nge a tum ber? It's amyloid plaques , Alzheimer natna thlentu lian ber nia ngaih a ni. Kan tui pipe-a rust a lo awm ang bawkin, heng plaque te hi thluaka nerve cell inkarah an lo awm a, an hnathawh a tibuai a ni. Donanemab hian a tih chu heng plaque te hi hriatchhuah a, tihbo pui hi a ni.

He damdawi hi engtiang chiahin nge a thawh?

Nikum lama clinical trial tihchhuah result atanga a lan dan chuan he enkawlna hian thla engemaw zat chhungin natna a zual zelna rate a ti hniam thei a ni.A theih tawh a ni. Hei hi damlote rilru lama theihna (e.g., hriatrengna, harsatna chinfel) leh nitin nunphung (e.g., lirthei khalh, sum enkawl) an thawh that dan tehna test hmanga teh a ni. Mithiam thenkhat chuan heng result te hi modest emaw "normal" emaw result an ti. Chumi awmzia chu hei atang hian danglamna lian tak i beisei thei lo tihna a ni. Mahse, enkawlna engmah awm lovin a zual zel ai chuan thla tlemte chhungin natna hi a reh thei tih hi a ropui hle bawk. Enkawlna pek dan erawh chu damdawi hi thla tin vein (infusion) hmangin damlote hnenah pek thin a ni. Trial-a telte chu kum khat leh a chanve vel zet chu he enkawlna hi pek an ni tawh a ni.

Hlawkna a awm bakah hlauhawmna lian tak a awm bawk.

Damdawi chak tak ang bawkin donanemab hian hlawkna a nei a, chubakah side effect leh risk na tak a nei bawk. Thutlukna siam hmain a lam leh lam hriatthiam a pawimawh. Heng zawng zawng ngaihtuah chung hian FDA advisory panel chuan a tawpah chuan he damdawi hlawkna hian a hlauhawmna aiin a tam zawk tih an rel ta a ni.Chumi awmzia chu damlo dik tak, enkawlna mumal hnuaia pek a nih chuan a hlawkna a tam zawk tihna a ni.

Hei chauh hi damdawi thar awmchhun a ni em?

Ni lo, chutiang bawka hnathawk damdawi dang a awm bawk. A hming chu lecanemab an ti a . Chu damdawi chuan thluaka platelet awm khawmte chu a target-in hna a thawk bawk. July 2023 khan FDA phalna a hmu a, chu zinkawngah chuan Donanemab hi step dang a ni. Khawvela Alzheimer’s association lar tak takte chuan hetiang enkawlna thar hi beiseina sang tak an nei a ni. An sawi dan chuan, "Hetiang enkawlna pawmpui a chhuah tam poh leh damlote chu an tlin theihna chance a sang zawk a ni. Enkawlna kawngah hmasawnna chiang tak a awm mek a ni," an ti. Tunah hian khawvel hmun hrang hrangah mi maktaduai tam takin Alzheimer natna an vei mek a ni. He natna hi a taka ven theih dan leh tihdam theih dan tur a la awm lo. Chuvangin, chu zinkawng thui takah chuan donanemab ang damdawi hi thil pawimawh tak a ni. Alzheimer’s Disease, donanemab, thluak natna, hriatrengna hloh, dementia, enkawlna thar, monoclonal antibody